Author: Director Statistics and Programming3. DATA SOURCES/STUDIES INCLUDED..................................................................7 4. PLANNED ANALYSES ................................................
Author(s): Indication Studied: Chronic Obstructive Pulmonary Disease1. INTRODUCTION ...2. STUDY OBJECTIVE(S)...3. INVESTIGATORS AND STUDY ADMINISTRATIVE STRUCTURE...4. INVESTIGATIONAL PLAN ...
Author(s): Indication Studied: Asthma4. STUDY OBJECTIVE(S). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.1. Primary Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
and placebo nasal spray (batch nos.. Subjects were to administer a single dose of investigational product into one nostril within 30 minutes of headache pain becoming moderate or severe. In the event of partial relief or recurrence, subjects could take a second dose of investigational product or...
Medical Institution: CPC Clinical Trial Hospital, Medipolis Medical Research Institute Investigator : Toso 4-18-38, Kagoshima, 890-0081, Japan TEL : Laboratories6.2.2. Sample Size Sensitivity...23 6.2.3. Sample Size Re-estimation...23 6.3. Data Analysis Considerations ......
Riverside CenterAuburndaleMATel Fax Internet: www.ingenix.com